Intercept Pharmaceuticals' Series B Round

Intercept Pharmaceuticals raised a round of funding on January 14, 2010. Investors include Genextra.

Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease utilizing expertise in bile acid chemistry. The…

Articles about Intercept Pharmaceuticals' Series B Round: